Geneva, Switzerland, March 13, 2020 a??
Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, will discuss its full year 2019 financial results, provide a business update and review its pipeline during a teleconference and webcast for investors, analysts and the media on Thursday, March 19, 2020 at 16:00 CET (14:00 GMT/10:00 ET).Title:A A A A A A A A A A A A A A A A A A A Addex Full Year 2019 Financial Results Conference Call
Date:A A A A A A A A A A A A A A A A A A March 19, 2020
Time:A A A A A A A A A A A A A A A A A 16:00 CET (14:00 GMT/10:00 ET)Joining theA Conference Call:
1: In the 10 minutes prior to the call start time, call the appropriateA participant dial-in number.A A A
Dial-In Numbers:
SwitzerlandA A A A A A A A A A A A A A A A A A A A A A +41 44 580 65 22
UKA A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A +44 20 30 09 24 70
U.S.AA A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A +1 87 74 23 08 30
Other Countries2: Provide the Operator with the Participation Pin
Code: 63704995#A A A A A A A Link to live event online:
1: In the 10 minutes prior to the call start time, sign in online by following this link
Webex Link.
2: Password: Welcome